Wyoming Administrative Code
Agency 059 - Pharmacy, Board of
Sub-Agency 0001 - Pharmacy, Board of
Chapter 13 - NON-STERILE COMPOUNDING
Section 13-7 - Compounding Controls
Current through September 21, 2024
(a) A Master Compounding Record shall be established for each newly compounded item and followed thereafter to monitor the output and to validate the performance of those compounding processes. The Master Compounding Record shall contain:
(b) Components for compounding shall be accurately weighed, measured, or subdivided as appropriate. If a component is transferred from the original container to a new container, the new container shall be labeled with the same information as the original container and the date of transfer.
(c) Written control procedures shall be established to monitor the output and to validate the performance of those compounding processes that may be responsible for causing variability in the final drug product. Such control procedures shall include, but are not limited to, the following (where appropriate):
(d) At the time of dispensing to the patient, the pharmacist shall advise the patient on the proper storage, use, and anticipated shelf life of the compounded prescription product.